0R0T.L - Amgen Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3N/A
S&P500 52-week change 32.72%
52-week high 3246.69
52-week low 3245.74
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8533.2M
% held by insiders 10.22%
% held by institutions 179.83%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 37.95
Trailing annual dividend yield 33.22%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 30.23%
Operating margin (ttm)36.83%

Management effectiveness

Return on assets (ttm)8.15%
Return on equity (ttm)252.78%

Income statement

Revenue (ttm)26.19B
Revenue per share (ttm)49.00
Quarterly revenue growth (yoy)-2.10%
Gross profit (ttm)19.92B
Net income avi to common (ttm)7.92B
Diluted EPS (ttm)10.12
Quarterly earnings growth (yoy)92.50%

Balance sheet

Total cash (mrq)31.56B
Total cash per share (mrq)59.07
Total debt (mrq)61.6B
Total debt/equity (mrq)1,151.74
Current ratio (mrq)3.14
Book value per share (mrq)10.01

Cash flow statement

Operating cash flow (ttm)8.62B
Levered free cash flow (ttm)7.95B